Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Foresite Capital Management VI LLC
Form 13F · Q2 2026

Foresite Capital Management VI LLC

CIK 2013341申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$6.4亿
申报组合市值
23
持仓数量
7
Quarters on record
Top 50
持仓数量

Foresite Capital Management VI LLC——持仓

共 23 个持仓中的前 23 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1CGON Cg Oncology Inc2.4M+6.7%$1.7亿26.2%
2ALMS Alumis Inc4.2M+0.0%$1.2亿18.6%
3SPTX Seaport Therapeutics Inc1.8M—$3865万6.0%
4DNLI Denali Therapeutics Inc1.4M+15.4%$3592万5.6%
5CLDX Celldex Therapeutics Inc New879,713+178.5%$3273万5.1%
6AGIO Agios Pharmaceuticals Inc785,000+49.5%$2913万4.5%
7CRVS Corvus Pharmaceuticals Inc1.8M+0.0%$2736万4.3%
8PBLS Parabilis Medicines Inc999,044—$2734万4.3%
9GHRS Gh Research Plc940,493+198.1%$2528万3.9%
10JBIO Jade Biosciences Inc886,667+177.1%$1970万3.1%
11HNGE Hinge Health Inc220,400+0.0%$1829万2.8%
12KYMR Kymera Therapeutics Inc146,332+0.0%$1678万2.6%
13ATAIBECKLEY INC Ataibeckley Inc2.8M+0.0%$1449万2.3%
14VSTM Verastem Inc3.1M+0.0%$1202万1.9%
15BEAM Beam Therapeutics Inc330,000—$1133万1.8%
16NERV Minerva Neurosciences Inc2.0M−0.1%$1102万1.7%
17AVBP Arrivent Biopharma Inc301,341—$1047万1.6%
18AURA Aura Biosciences Inc1.3M—$947万1.5%
19CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In212,010+0.0%$793万1.2%
20RACC Research Alliance Corp Iii300,000—$321万0.5%
21ZURA Zura Bio Ltd450,000+0.0%$266万0.4%
22KLRA Kailera Therapeutics Inc37,500—$83万0.1%
23IRON Disc Medicine Inc970—$7万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。